Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Return on Invested Capital [ROIC] (2014 - 2026)

Updated

Regeneron Pharmaceuticals (REGN) posted Return on Invested Capital [ROIC] of 9.60% for Q2 2026, down 1.50 percentage points from 11.10% a year earlier but up 0.26 percentage points from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Return on Invested Capital [ROIC] (2014 - 2026) Analysis & Trends

For FY2025, Regeneron Pharmaceuticals' Return on Invested Capital [ROIC] came in at 9.54%, down 2.88 percentage points from FY2024.

  • Annual Return on Invested Capital [ROIC] has declined for four consecutive years, with a five-year change of -17.83 percentage points (FY2020 to FY2025).
  • In prior years, Regeneron Pharmaceuticals' Return on Invested Capital [ROIC] was 12.43% in FY2024 (-2.06 pp), 14.49% in FY2023 (-4.16 pp), 18.64% in FY2022 (-27.26 pp) and 45.91% in FY2021 (+18.53 pp).
  • Quarterly Return on Invested Capital [ROIC] has run from a low of 9.31% in Q4 2025 to a high of 38.75% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Invested Capital [ROIC] has declined in each of the last 17 quarters, with an average year-over-year change of -1.93 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Invested Capital [ROIC] in the past five years was Q4 2021, with a gain of 12.48 percentage points; the weakest was Q1 2023, with a drop of 21.17 percentage points.
  • According to Business Quant data, Return on Invested Capital [ROIC] for the three prior quarters was 9.34% (Q1 2026), 9.31% (Q4 2025) and 10.12% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 16.10%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 18.68%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 3.56%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 34.87%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 23.26%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 14.33%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -5.97%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 13.44%
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 9.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.60%
Mar 31, 2026 9.34%
Dec 31, 2025 9.31%
Sep 30, 2025 10.12%
Jun 30, 2025 11.10%
Mar 31, 2025 11.03%
Dec 31, 2024 11.76%
Sep 30, 2024 12.10%
Jun 30, 2024 12.44%
Mar 31, 2024 12.91%
Dec 31, 2023 13.90%
Sep 30, 2023 14.56%
Jun 30, 2023 15.16%
Mar 31, 2023 15.87%
Dec 31, 2022 17.61%
Sep 30, 2022 24.05%
Jun 30, 2022 27.58%
Mar 31, 2022 37.04%
Dec 31, 2021 38.75%
Sep 30, 2021 35.76%
API Access

Regeneron Pharmaceuticals Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=REGN&period=max&api_key=YOUR_API_KEY